Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001104659-23-108583
Filing Date
2023-10-11
Accepted
2023-10-11 16:34:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 tm2327968-1_sc14d9.htm SC 14D9 1144184
2 GRAPHIC lg_barclaysnew-4c.jpg GRAPHIC 11227
3 GRAPHIC lg_centerviewpart-4c.jpg GRAPHIC 17622
4 GRAPHIC ft_intercept-bw.jpg GRAPHIC 15802
  Complete submission text file 0001104659-23-108583.txt   1206036
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filed by) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-87033 | Film No.: 231321009
SIC: 2834 Pharmaceutical Preparations